Crispr

Charité Berlin has successfully treated a 19-year-old patient with the world's first CRISPR gene-editing therapy, marking the first time the treatment has been administered in Germany since receiving regulatory approval. The hospital described the case as a milestone in medicine, with ties noted to Nobel laureate Emmanuelle Charpentier, co-inventor of CRISPR gene editing.